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Sex differences for chronic back pain (cBP) have been reported, with females usually exhibiting 
greater morbidity, severity and poorer response to treatment. Genetic factors acting in an age-
specific manner have been implicated but never comprehensively explored. We performed sex- and 
age-stratified GWAS and SNP-by-sex interaction analysis for cBP defined as “Back pain for 3+ 
months” in 202,077 males and 237,754 females of European ancestry from UK Biobank. Two and 
seven non-overlapping genome-wide significant loci were identified for males and females, 
respectively. A male-specific locus on chromosome 10 near SPOCK2 gene was replicated in four 
independent cohorts. Four loci demonstrated SNP-by-sex interaction, although none of them were 
formally replicated. SNP-explained heritability was higher in females (0.079 vs 0.067, p = 0.006). 
There was a high, although not complete, genetic correlation between the sexes (r = 0.838±0.041, 
different from 1 with p = 7.8E-05). Genetic correlation between the sexes for cBP decreased with age 
(0.858±0.049 in younger people vs 0.544±0.157 in older people; p = 4.3E-05). There was a stronger 
genetic correlation of cBP with self-reported diagnosis of intervertebral disc degeneration in males 
than in females (0.889 vs 0.638; p = 3.7E-06). Thus, the genetic component of cBP in the UK Biobank 
exhibits a mild sex- and age-dependency. This provides an insight into the possible causes of sex- 








































































Epidemiological studies provide evidence for different risk of back pain (BP) between the sexes, with 
women usually demonstrating greater prevalence, severity and chronicity than men (2, 6, 10, 23, 36, 
41, 42, 45, 50, 55). This may be explained in part by variation in socioeconomic, biological and 
psychological factors (gender disparities, sex hormones, BMI, depression, pain behaviours) (6, 42, 45, 
55). However even after adjustment for these factors, females remain more affected by BP (42, 45). 
Sex differences also exist for the prevalence and severity of other chronic pain conditions (e.g. 
fibromyalgia, migraine, and irritable bowel syndrome), and their response to pain treatment (3) 
suggesting a general propensity for women to develop (or perceive and report) chronic pain rather 
than structural or anatomical differences.  
The phenomenon of sex-specificity in complex disease is well known and various factors have been 
implicated, including hormone profiles and behavioural factors (40, 49, 52). Apart from these, 
genetic factors have also been considered as one of the possible contributors (20, 24, 35, 39, 51). 
While mechanisms of sex-specificity in chronic pain have been rigorously studied with respect to 
hormone levels, pain perception, psychosocial and behavioural factors (comprehensively reviewed in 
(3, 16)), few studies have explored the sex-specific impact of genetics on pain (4, 31, 33, 53). 
Classical twin studies provide some evidence for differential contribution of genetic factors to BP in 
males and females. Even though in a younger sample (16-41 years) no differences in heritability for 
lifetime risk of BP was observed between the sexes (22), different heritability estimates for BP have 
been obtained in people aged 70 years and older with modest additive genetic effects in men, but 
not in women (21). The same trend was observed for chronic neck pain (15). Using both a SNP-based 
approach and classical twin modelling, differential heritability estimates for the sexes have been 
demonstrated in a number of traits having high genetic or phenotypic correlation with BP such as 
waist circumference (19), obesity-related anthropometric traits (12, 19), subjective well-being (34), 
and insomnia (13). This raises the interesting possibility that sex-specific genetic risk factors for BP 
may explain sex-specificity in BP.  
We have previously examined the UK Biobank dataset (47) to study genetic associations with BP, 
identifying three genome-wide significant loci (18). In the current study we set out to carry out SNP-
by-sex interaction analysis for chronic BP (cBP), defined as BP lasting at least 3 months. We also 










































































The study pipeline is overviewed on Figure 1. First, we carried out sex- and age-specific GWASs for 
cBP in the discovery sample of Europeans from UK Biobank. Second, we carried out SNP-by-sex 
interaction analysis for sex-specific genetic markers. Third, we performed replication analysis of sex-
specific loci and significant SNP-by-sex interaction loci in four independent cohorts. Then, we 
estimated and compared SNP-based heritability between the sex- and age-specific groups. Finally, 
we carried out a comparative sex- and age-specific analysis of genetic correlations for cBP and a 
wide range of complex traits from a publicly available database.  
Sample and phenotype definition 
The discovery sample for the study has been taken from UK Biobank, a resource following health and 
well-being of over 500,000 volunteer participants. The details of recruitment and assessment of the 
participants are described in full elsewhere (47). Briefly, the participants comprise people aged 40-
69 year at the time of recruitment who were registered with a general practitioner in the UK. The 
participants were enrolled in 2006-2010 in 22 assessment centres in England, Wales, and Scotland 
and completed detailed touch-screen questionnaires on their demographics, lifestyle, health, and 
environment. Invitations to take part in UK Biobank have been issued to about 9.2 million 
individuals, of which about 5.5% accepted. Among other items, self-reported ethnic background has 
been assessed (White, Asian or Asian British, Black or Black British, Chinese, Mixed, and other). 
Additionally, genetic principal components have been used by UK Biobank to identify a more 
genetically homogeneous group of white Europeans (Caucasians) among those who self-classified as 
“White British". 
For the purpose of the current study, we used the discovery sample comprised 451,324 European 
participants of UK Biobank who self-classified as “White British” ethnicity and were genetically 
similar by genetic principal components, as well as individuals who belonged to the same genetic PC 
cluster as the “White British” despite self-reporting other ethnic ancestry as described previously 
(18). 
The phenotype of cBP was defined through a combination of the UK Biobank data-fields 6159 
accumulating responses to the question: “Pain type(s) experienced in last month” and the UK 
Biobank data-field 3571: “Back pain for 3+ months”. Those who indicated “Back pain” in response to 
the data-field 6159 (Pain types(s)) question and also replied “Yes” to the data-field 3571 (Back pain 
for 3+ months) question, were classified as cases. Those who did not indicate “Back pain” in 




































































controls. Individuals who replied “Do not know” or “Prefer not to answer” to any of the questions 
were excluded. We also excluded those who reported the presence of “General pain for 3+ months” 
(data-field 2956) as this may represent chronic widespread musculoskeletal pain or fibromyalgia. 
The remaining sample comprised 439,831 individuals including 202,077 males (35,705 cases, 17.7%) 
and 237,754 females (43,230 cases, 18.2%). Mean age (±SD) in males and females was 57.5±8.1 and 
57.1±7.9 years, respectively, and mean BMI was 27.9±4.2 and 27.0±5.1 kg/m2, respectively.  
Replication was carried out using European individuals from four datasets: Generation Scotland: 
Scottish Family Health Study (UK); the Orofacial Pain: Prospective Evaluation and Risk Assessment 
(OPPERA) cohort (US); the Nord-Trøndelag Health Study (HUNT) cohort (Norway); and the English 
Longitudinal Study of Aging (ELSA) cohort (UK) (Table 1).  
Generation Scotland is a family-based genetic epidemiology study of 24,000 volunteers across 
Scotland aged 18-98 years (44). The replication sample for the current study comprised 19,599 
individuals including 8,023 males and 11,576 females. The phenotype of chronic back pain was 
defined as the following. Participants first answer a question: “Are you currently troubled by pain or 
discomfort?”; those who reply positively are queried: “Have you had this pain or discomfort for 
more than 3 months?". To those who reply positively, the questionnaire gives specific sites 
participants can select: back pain; neck or shoulder pain; headache; facial or dental pain; stomach 
ache or abdominal pain; pain in your arms, hands, hips, legs or feet; chest pain; and other pain. 
Accordingly, the definition of chronic back pain cases in GS: those who selected Back pain option, 
while the controls – all other participants.  
OPPERA is a project aiming to investigate the impact of genetic, physiological, psychological and clinical 
factors on the development of painful temporomandibular disorder (1). The replication sample for the 
current study comprised 1,584 individuals including 575 males and 1,009 females. The phenotype of 
chronic back pain was defined using the comprehensive pain survey questionnaire as the following: 
Participants that reported having more than 5 episodes of back pain in the last year and those that 
reported between 2-4 episodes last year and that the episode lasted more than two hours. Participants 
reporting chronic widespread pain and fibromyalgia were excluded. 
The HUNT study is a population-based cohort of 125,000 Norwegian participants recruited during three 
waves between 1984-2008 (25). The replication sample for the current study comprised 66,534 
individuals including 32,362 males and 34,172 females. The phenotype of cBP was defined as the 
following. The questionnaire data were used, with the participants who have replied “Yes” to ‘During 
the last year, have you suffered from pain and/or stiffness in your muscles and joints that has lasted 




































































to the question ‘Where did you have these complaints?’, were classified as having cBP. Participants 
who self-reported or had hospital-diagnosed fibromyalgia were excluded both from cases and 
controls for greater compatibility with the UK Biobank definition of cBP used in the current study. 
ELSA cohort is a longitudinal study of more than 27,000 individuals recruited during eight waves since 
2002 (46). The replication sample for the current study comprised 6,115 individuals including 2,780 
males and 3,335 females. The phenotype of cBP was defined as the following. The questionnaires 
across waves 3 to 8 were assessed and those who positively responded to the questions “Whether 
often troubled with pain” and “Whether feel pain in back” were considered to have BP during a 
particular wave, while those who replied negatively to the first and/or second question were 
considered not to have BP. After obtaining these data in each wave separately, those who were 
cases in at least two waves were defined as cBP cases, while the rest were defined as controls. 
Genome-wide association study 
GWAS in the discovery sample was carried out in males and females separately using BOLT-LMM v 
2.3.2 (27). Linear additive genetic model was fitted adjusting for age, genotyping array type and the 
first 10 genetic principal components provided by UK Biobank. The following filters were applied: 
minor allele frequency >0.001, genotyping and individual call rates >0.98%, imputation quality score 
(INFO) >0.7. A total of 14,828,942 autosomal and X-chromosomal biallelic single nucleotide 
polymorphisms (SNPs) and short insertions/deletions remained after filters applied were analysed. 
The genome-wide significance threshold was taken as p < 2.5E-08 accounting for two GWAS studies 
in males and females.  
Leading independent SNPs in associated loci were established by Conditional and Joint Association 
(COJO) analysis (57). This method tests significant SNPs in the locus of association and identifies 
genetic variants having the strongest effect independent of the presence of other variants in linkage 
disequilibrium (LD). LD score regression was applied to quantify the impact of polygenicity and 
unobserved confounders on the results of GWAS (9). The proportion of cBP risk variance explained 
by the analysed genetic factors (SNP-based heritability) was calculated using BOLT-LMM v2.3.2 and 
compared between males and females using z-statistic (38). 
SNP-by-sex interaction analysis 
SNP-by-sex interaction analysis was carried out via a comparison of SNP-effect size (regression 
coefficients from GWAS) in males and females using t-statistic (38). Prior to estimating the t-statistic, 
SNP-effects and standard errors were scaled by dividing them by the phenotype variance to account 




































































the comparison groups. This was performed for lead SNPs from male- and female-specific GWAS 
only (n = 9); accordingly, the significance threshold was set as p = 0.05/9 = 0.0056. 
Replication 
For replication, association analyses were carried out in each cohort separately using appropriate 
software (Table 1). OPPERA cohort applied logistic regression adjusting for age, genetic principal 
components and technical covariates. Other cohorts applied linear mixed-effects models adjusting 
for age, cohort-specific covariates and relatedness via genetic kinship matrices. Meta-analysis of the 
replication cohorts was performed by Z-score approach implemented in METAL software (56) for 
sex-specific GWAS signals and by Fisher’s combined probability test for SNP-by-sex interaction (17). 
Genetic correlations  
Genetic correlation is a measure of similarity between traits due to shared genetic factors. LD score 
regression was used to calculate the genetic correlations (8). Genetic correlations were calculated 
for cBP in males vs females; also they were calculated in sex-stratified groups between cBP and 832 
complex traits available on LDhub (8, 59) and ten traits considered as putative risk factors for BP, 
which have previously been identified as having statistically significant genetic correlation with BP 
(18): osteoarthritis, self-reported intervertebral disc problems, scoliosis, smoking, BMI, well-being, 
intelligence, educational attainment, anxiety, and depression. Genetic correlations between cBP and 







































































Age-specific prevalence of chronic back pain in UK Biobank 
The prevalence of cBP in the total sample of 439,831 European individuals from UK Biobank was 
significantly lower in males vs females: 17.7% vs 18.2%, p = 1.4E-08. The prevalence of cBP in males 
remained fairly constant over age, while in females there was a gradual increase in prevalence with 
age, becoming significantly different between the sexes > 65 years (Figure 2). This pattern of higher 
cBP prevalence in older females is consistent with the results of meta-analysis of other cohorts (54). 
Based on this we divided the sample into two age strata “Younger than 65” (n= 158,245 males; n = 
193,265 females) and “65+” (n= 43,832 males, n = 44,489 females). In the younger group, prevalence 
of cBP was the same in males and females (17.7%) but the older group showed statistically 
significantly higher prevalence among females (17.7 vs 20.2%; p = 0.002). Subsequent sex-specific 
genetic analysis was carried out in the total sample and within age strata.  
 
Sex-specific genetic loci for chronic back pain 
The results of GWAS for cBP in for males and females from UK Biobank are shown in Figure 3 and in 
Table 2. In males, 2 associated genetic loci were identified with the lead SNPs rs1678626 
(10:73826335; at SPOCK2; β = -0.0068±0.0012; p = 2.4E-08), and rs72922230 (18:50394407; at DCC; 
β = -0.0069±0.0012; p = 2.4E-08). In females, 7 genetic loci were identified: rs367563576 
(1:150495378; near LINC00568; β = 0.0067±0.0012; p = 7.6E-09), rs62327819 (4:147211141; at 
SLC10A7; β = -0.0070±0.0012; p = 8.1E-09), rs1039325 (5:30761421; near RP11-136H13.2; β = -
0.0065±0.0011; p = 8.7E-09), rs116007789 (7:101223945; near LINC01007; β = -0.0785±0.0133; p = 
3.3E-09), rs7834973 (8:69639672; at C8orf34; β = -0.0068±0.0012; p = 4.2E-09), rs12308843 
(12:23974404; at SOX5; β = -0.0103±0.0013; p = 9.4E-15), and rs2391333 (13:107166694; at EFNB2; 
β = -0.0066±0.0012; p = 1.9E-08).  
In both sexes, LD score regression indicated high polygenicity and no evidence for confounding in 
the results of GWAS (for males: λ GC = 1.1459, intercept  = 1.0093±0.0074, and ratio (the impact of 
confounder-driven inflation) = 0.0530±0.0419; for females, λ GC = 1.2005, intercept = 
1.0053±0.0068, and ratio = 0.0215±0.0273). 
The genome-wide significant loci observed in males and females were mutually exclusive: i.e., 
genome-wide significant loci for one sex were not genome-wide significant in the other sex. 
Moreover, for 4 of the loci detected in females, the effect sizes were statistically significantly 




































































(1:150495378; adjusted pint = 0.0315); rs62327819 (4:147211141; adjusted pint = 1.0E-08); rs1039325 
(5:30761421; adjusted pint = 0.0243); and rs2391333 (13:107166694; adjusted pint = 0.0045). 
 
Replication of sex-specific associations 
Replication was attempted for the lead 9 SNPs using 4 independent cohorts (Table 3). One out of the 
nine loci was replicated after adjusting for multiple testing (p<0.0056=0.05/9): the locus tagged by 
rs1678626 on chromosome 10 near SPOCK2 gene in males (Z = -2.992; p = 0.0028). The direction of 
the effect for rs1678626 was consistent across samples (rs1678626*T allele is protective). The locus 
tagged by rs62327819 on chromosome 4 near SLC10A7 gene exhibited a significant p-value in 
females (Z = 2.818; p = 0.0048), but had opposite direction of effect (rs62327819*C allele in 
protective in discovery, but risk-increasing in replication). Also, in females a nominally significant 
replication was observed for the chromosome 13 locus near EFNB2 gene tagged by rs2391333 (Z = 
2.237; p = 0.0253). The strongest signal in the discovery in females on chromosome 12 near SOX5 
tagged by rs12308843 was not replicated (Z = -1.885; p = 0.0595) but showed the same direction of 
the effect (rs12308843*G allele is protective).  
 
Replication of top SNP-by-sex interaction signals 
Replication was attempted for the top SNPs in the 4 regions of the significant SNP-by-sex 
interactions (Table 4; Supplementary Figure 1). Either the top SNPs or proxy SNPs with LD>0.9 with 
the top SNP depending on the availability in replication cohorts were used. Only for the locus on 
chromosome 4, Fisher’s combined probability test suggested a statistically significant SNP-by-sex 
interaction (χ2 = 22.9, df=8, p = 0.0035; Table 4). However, despite it appearing to replicate, there is 
a discrepancy in the direction of effect between UK Biobank and the replication cohorts. Namely, in 
UK Biobank the rs7682719*T allele is positively associated with cBP in males and negatively in 
females, resulting in a positive sign for t-statistics for interaction (Table 2; Supplementary Figure 1), 
while the t-statistics in all replication studies are in the opposite direction (Table 2; Supplementary 
Figure 1). Also, there is a discrepancy in nominally significant associations in the replication cohorts. 
Namely, the SNP is nominally associated with BP in males in OPPERA, while it is nominally associated 
with BP in females in HUNT and ELSA (which is consistent with UK Biobank results). Thus, the results 






































































SNP-heritability of chronic back pain by sex and age 
In both age groups the SNP-based heritability was higher in females, and this effect was the most 
pronounced in the “65+” age group (Table 5). Trends towards lower heritability in males over age 65 
and higher heritability in females over age 65 was observed, though these did not reach statistical 
significance. Genome-wide summary statistics were also available for Generation Scotland which 
allowed estimating SNP-based heritability. Consistent with the findings in UK Biobank, estimated 
heritability was higher in females compared to males in Generation Scotland: 0.129±0.020 vs 
0.064±0.027, respectively, with a borderline statistical significance of the difference (p = 0.053).   
 
Sex-specific genetic correlation 
We estimated and compared the genetic correlation for cBP between males and females and also 
compared the genetic correlation for cBP and its risk factors between males and females. We 
applied both a hypothesis-driven approach using 10 traits considered to be risk factors for cBP and 
an agnostic approach using all complex traits available on LDHub. 
The sexes were highly genetically correlated for risk of cBP, particularly in the young: total sample, 
0.8377±0.0406 (p = 1.8E-94); “Younger than 65” age group, 0.8582±0.0494 (p = 1.3E-67); and “65+” 
age group, 0.5444±0.1565 (p = 5.0E-04). Between-sex genetic correlations within the age groups 
were statistically significantly different (p = 4.3E-05) (Figure 4, left panel). At the same time, 
between-age genetic correlation within sex strata did not differ significantly: 0.7656±0.1209 vs. 
0.8585±0.0948 in males and females, respectively (p = 0.072) (Figure 4, right panel).    
In females there was a significant genetic correlation between cBP and 9 of the 10 risk factors 
(except anxiety/panic attacks) (Table 6). For males genetic correlation was seen between cBP with 
most risk factors except anxiety/panic attacks and scoliosis (Table 6). A significant difference in 
genetic correlation in males and females was observed for self-reported intervertebral disc 
problems: rg = 0.889 vs rg = 0.638 in males and females, respectively (padj = 6.7E-06). Also, nominally 
significant differences of genetic correlation were found for cBP with peripheral joint osteoarthritis 
and BMI: p = 0.042 and 0.045, respectively. 
Next, we analysed the genetic correlation between cBP and 10 risk factors as above by age groups 
followed by a comparison between them. In the “Younger than 65” group the genetic correlation in 
males and females were similar to that of the whole sample (Supplementary Table 1) including the 
difference in genetic correlation for self-reported intervertebral disc problems: 0.866 vs 0.659 in 




































































differences compared to the whole sample were observed: no statistically significant genetic 
correlations of chronic BP with depression and smoking in males, no correlation with scoliosis in 
females, and no correlation with anxiety in either sex group (Supplementary Table 1). Again, in the 
“65+ group” there was a significant difference in genetic correlation between the sexes for self-
reported intervertebral disc problems: 0.806 vs 0.480 in males and females, respectively (padj = 
0.040). There was a nominally significant difference in correlation with depression: 0.137 vs 0.439 in 
males and females, respectively (p = 0.008).  
Genetic correlation of cBP with 832 traits available on LDHub were filtered via removal of traits that 
did not pass LDHub internal quality criteria and those involving back pain definitions (Back pain, 
chronic back pain, dorsalgia, and “None of the above“ response to question “Pain type(s) 
experienced in last months”). We adjusted the p-value for the number of the remaining traits (n = 
747) and additionally removed traits that were non-significant after adjustment for multiple testing 
in both sexes. A total of 297 traits remained that were significantly correlated with cBP in at least 
one sex (Supplementary Table 2), of which 2 traits exhibited statistically significantly different 
genetic correlations in males vs. females after accounting for multiple comparisons: “Neck or 
shoulder pain experienced in last months” (0.7405 vs 0.8349 in males and females, respectively; padj 








































































The current study tested the hypothesis that sex- and age-specificity exists in the genetic 
predisposition to cBP. The results of the study suggest small but statistically significant differences in 
SNP-based heritability in males and females (consistently observed in UK Biobank and Generation 
Scotland). We identified two and seven genome-wide significant loci in males and females, 
respectively. Comparing the results of the current study with our previous findings (18, 48) reveals 
that the loci SPOCK2 and DCC found previously are driven by males, while the loci C8orf346 and 
SOX5 seen in previous studies are driven by females.  
Only one locus was replicated in the four independent cohorts: SPOCK2 in males. The lack of 
replication for other loci may in part be explained by the low power attributable to the rather small 
effect sizes that achieve significance only upon the use of such a large sample as UK Biobank. 
However, for the strongest locus in females on chromosome 12 near SOX5 the power for replication 
was estimated at 95% considering a single locus and 81% considering 9 loci. For the SLC10A7 locus in 
females we detected significant by p-value replication signal although the direction of the effect was 
opposite in replication compared to UK Biobank. The opposite effect of the SLC10A7 locus between 
UK Biobank and replication cohorts raises a possibility of a flip-flop effect, reported seen in a number 
of genetic studies of complex human traits (26, 60). The phenomenon is thought to be based on the 
variable patterns of LD between the causal and marker SNPs and/or by the variation in the 
prevalence of the causal SNP (58). In particular, the effect direction of a weak marker SNP may be 
driven by the direction of the effect of linked strong causal variants, not explicitly analyzed in a 
GWAS (e.g. rare variants). At the same time, in another population these strong causal variants may 
be absent, too rare, or have a different LD pattern, so the direction of effect will be specific for the 
weak SNP and may be opposite for strong variants resulting in the observed flip-flop in the effect 
direction.  
In total, four of nine sex-specific genomic loci exhibited significant SNP-by-sex interaction. For the 
locus on chromosome 4 near SLC10A7 gene, effect direction in replication cohorts was opposite to 
the UK Biobank; as above. Considering a possibility of a flip-flop effect, the SLC10A7 locus may be of 
interest for an in-depth analysis for SNP-by-sex interaction in cBP. None of the other loci were 
replicated in the independent cohorts. Thus, it is difficult to conclude if the observed SNP-by-sex 
interactions are specific to the UK Biobank dataset, or replication cohorts were not of sufficient size 
to detect an association.  
Potentially interesting observations include the larger genetic correlation of cBP with self-reported 




































































illness/injury or assault and neck or shoulder pain in females vs. males. The situation with 
intervertebral disc problems and neck or shoulder pain is consistent with the different prevalence of 
these traits in males and females: in people with cBP, the prevalence of self-reported disc problems 
was higher in males than in females (0.076 vs 0.063; p = 5.5E-13) consistent with higher genetic 
correlations in males compare to females; the prevalence of neck pain was lower in males than in 
females (0.420 vs 0.471; p < 2.2E-16) consistent with higher genetic correlations in females 
compared to males. However, the prevalence of serious illness/injury or assault to yourself was 
higher in males with cBP than in females (0.162 vs 0.133; p < 2.2E-16), opposite to the expectation 
based on the differences in genetic correlations that was higher in females. The difference in genetic 
correlation between males and females may in part reflect the different impact of other factors 
related to cBP, rather than only differential genetic background between the sexes. For example, 
one such factor may be doctors’ diagnoses: UK General Practitioners may more readily assign a 
diagnosis of disc degeneration to males rather than females in the presence of cBP, due to a greater 
social acceptability of cBP in males attributable to an underlying structural problem. This type of 
social desirability bias could be driven by the attitudes or beliefs of both practitioners and patients 
and may reflect referral bias for imaging studies. Alternatively, pleiotropy of cBP with disc 
degeneration, neck pain and injury history may truly differ between the sexes.  
Important observations were made examining the genetic background of cBP by age. Namely, we 
found variation in SNP-based heritability including its trend to decrease with age in males and 
increase in females. For many complex traits, heritability tends to decline with age but for some 
traits the opposite trend has also been reported (5, 7, 32, 37, 43). Explanations of this phenomenon 
include varying contribution of environmental influence with age as well as different genetic factors 
contributing to the risk of diseases or phenotypes manifestation in different age groups (37). 
Similarly, the same disease phenotype may reflect different underlying pathology at different ages 
(32).  
Genetic correlation for cBP between males and females fell with age, too. Finally, the structure of 
genetic correlations of cBP and its putative risk factors changed with age. In particular, there was a 
decline in genetic correlation between cBP and depression in males with age, which was not seen in 
females, leading to a large magnitude difference in cBP vs depression genetic correlation between 
males and females in the “65+” age group: 0.137 vs 0.439; p = 0.008. Interestingly, the prevalence of 
depression among people with cBP was lower in males than females in both age groups: 0.077 vs 
0.123, p < 2.2E-16, in males and females, respectively, in the “Younger than 65” group; and 0.046 vs 
0.078, p < 2.2E-16, in males and females, respectively, in the “65+” group. Overall, this suggests 




































































It should be noted that previously genetic correlation between the same trait estimated in family 
members in different environments (in our cases environment is the gender and age) have been 
used as an indicator of the gene-environment interaction (28). Falconer (14) suggested that the 
same trait measured in two different environments can be treated as two different traits. If the 
family genetic effects do not change across environments or if they are related such that 
performance of any genotype in environment 2 is proportional to that in environment 1, the genetic 
correlation of family members across environments is equal to one. The null hypothesis of no 
significant gene-environment interaction is rejected whenever the genetic correlation across 
environments is significantly less than one. In our case we used the ideologically similar approach for 
calculation of genetic correlation using GWAS results calculated in different environments. So, given 
the genetic correlation significantly less than one between males and females and between young 
and old, we suggest the existence of gene-by-sex and gene-by- age interactions. These estimates 
may still be biased by confounders having differential influence on the trait in different 
environments.   
The study has several limitations. Most of the phenotypes explored were based on self-assessment 
and are inherently subject to recall bias. This is especially the case for a loosely defined phenotype of 
cBP. However, as has been seen with other complex phenotypes, self-reported measures may be 
fully comparable with objective measures (11). Concerning pain phenotypes specifically, UK Biobank 
data have been shown to be representative of general population and consistent with other studies 
in terms of chronic pain prevalence and its association with social, demographic, and psychological 
risk factors (29). Another limitation is the lack of consistency in cBP phenotype definition between 
the cohorts; this, further complicated by the different prevalence of the phenotype in replication 
cohorts, might have been one of the reasons we did not replicate the majority of sex-specific 
genomic loci and SNP-by-sex findings. Finally, we chose to focus only on the loci that were significant 
in sex-specific GWASs, while a genome-wide SNP-by-sex interaction analysis is warranted. However, 
the methodology of such the analysis is not yet fully developed and inherently low power for GxE 
analysis remains a major challenge (30), especially for such a complex and heterogeneous 
phenotype as BP.  
Overall, our study suggests that the genetic component of cBP in the UK Biobank exhibits a mild sex- 
and age-dependency raising implications for age- and sex-stratified analysis of cBP. Such analyses 
may be fruitful for other types of chronic pain, musculoskeletal and somatic, given prior suggestions 
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Figure 1 – The study pipeline overview. Sex- and age-specific GWASs for cBP in the discovery sample 
of Europeans from UK Biobank was carried out. Replication analysis for sex-specific genome-wide 
significant loci was performed in four independent European cohorts: HUNT (Norway), Generation 
Scotland (GS, UK), OPPERA (USA), and ELSA (UK). Next, we carried out SNP-by-sex interaction 
analysis for sex-specific genetic markers followed by replication analysis in the same cohorts. Then, 
we estimated and compared SNP-based heritability between the sex- and age-specific groups. 
Finally, we carried out a comparative sex- and age-specific analysis of genetic correlations for cBP 
and a wide range of complex traits. Details of the samples and methods used are provided in the 
Table 1 and the Methods section.  
Figure 2 – Prevalence of chronic BP by age in males and females in UK Biobank. The dataset has 
been split into equally sized bins based on quantiles of age distribution. Whiskers indicate 95% CI. * 
p < 0.05. The plot was produced using epiDisplay package for R (https://cran.r-
project.org/web/packages/epiDisplay/epiDisplay.pdf). 
 Figure 3 – Miami plot for sex-stratified GWAS for chronic back pain in Northern European sample 
from UK Biobank. Red line depicts the genome-wide significance threshold (p < 2.5E-08). Top panel 
shows the results for women, bottom panel shows the results for men. The plot was produced using 
EasyStrata package for R (www.genepi-regensburg.de/easystrata). 
Figure 4 – Genetic correlation between males and females by age group (left panel) and between 
the age groups by sex (right panel). Whiskers represent 95% CI. Between-sex genetic correlations 
were significantly different in the age groups (p = 4.3E-05), while between-age genetic correlations 
within same sex group were not (p = 0.072).  
Supplementary Figure 1 – Forests plots for sex-stratified effect sizes in UK Biobank and replication 
cohorts. Effect sizes in all cohorts except for OPPERA are transformed to log OR using the 
transformation β/(µ*(1-µ)), where β is linear regression effect size and µ is proportion of cases in the 
sample. This was done for compatibility with OPPERA cohort that was analysed using logistic 
regression. Details of cohorts are provided in Table 1. The plots were produced using foresplot 
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Table 1 – Discovery and replication cohorts 




(Scottish Family Health 
Study) 
OPPERA (Orofacial Pain: 
Prospective Evaluation 
and Risk Assessment) 
HUNT (The Nord-
Trøndelag Health Study) 
ELSA (English Longitudinal 
Study of Aging) 
Sample size Males 202,077 8,023 575 32,362 2,780 
 Females 237,754 11,576 1,009 34,172 3,335 
Cases / controls  Males 35,705 / 166,372 1,413 / 6,610 207 / 368 8,569 / 23,793 534 / 2,246 
 Females 43,230 / 194,524 2,454 / 9,122 478 / 531 11,247 / 22,898 960 / 2,375 
Age ± SD, years Males 57.5±8.1 47.32±15.19 27.44±7.26 48.1±16.50 64.85±21.29 
 Females 57.1±7.9 47.60±14.83 28.02±7.54 47.7±17.50 64.94±20.61 
BMI± SD, kg/m2 Males 27.9±4.2 26.93±4.52 25.68±4.72 26.6±3.60 25.85±7.79 
 Females 27.0±5.1 26.55±5.68 24.93±5.98 26.1±4.60 25.37±8.81 
Genotyping array  UK Biobank Affymetrix 
Axiom and UK BiLEVE 











Imputation panel  UK10K, 1000 Genomes 
phase 3, HRC.r1-1 
HRC.r1-1 1000 Genomes phase I Customized reference 
panel* 
1000 Genomes phase I 
Association analysis 
software 
 BOLT-LMM 2.3.2 GCTA64 PLINK1.9 SAIGE 0.35.8.3 GCTA64 
Legend to table 1: *The customized reference panel represented the merged panel of two reciprocally imputed reference panels: (1) 2,201 low-coverage whole-genome 
sequences samples from the HUNT study and (2) HRC v1.1 with 1,023 HUNT WGS samples removed before merging. 
Main Tables
Table 2 – Genome-wide significant (p < 2.5E-08) loci associated with chronic BP in males and females in the total UK Biobank sample 
Legend to table 2: Genome-wide association study for chronic BP in UK Biobank by sex. Conditional and joint analysis (COJO) was applied to identify 
conditionally independent SNPs. Bold results denote significant SNP-by-sex interactions. 
* According to SNP-nexus software (https://www.snp-nexus.org/) 
** P-values for SNP-by-sex interaction analysis (raw and adjusted for 9 tests) 
 










Univariate analysis Conditional and joint analysis Pint** 
Effect 
size 
SE P-value Effect 
size 
SE P-value Raw Adjusted 
Males rs1678626 10:73826335 SPOCK2 T C 0.445 -0.0068 0.0012 2.40E-08 -0.0068 0.0012 2.37E-08 0.1857 1.000 
 rs72922230 18:50394407 DCC A G 0.598 -0.0069 0.0012 2.40E-08 -0.0069 0.0012 2.41E-08 0.1143 1.000 
Females rs367563576 1:150495378 LINC00568 T TAC 0.609 0.0067 0.0012 7.60E-09 0.0067 0.0012 7.66E-09 0.0035 0.0315 
 rs62327819 4:147211141 SLC10A7 C T 0.322 -0.0070 0.0012 8.10E-09 -0.0070 0.0012 8.10E-09 1.15E-09 1.04E-08 
 rs1039325 5:30761421 RP11-136H13.2 T G 0.417 -0.0065 0.0011 8.70E-09 -0.0065 0.0011 8.77E-09 0.0027 0.0243 
 rs116007789 7:101223945 LINC01007 C T 0.998 -0.0785 0.0133 3.30E-09 -0.0785 0.0133 3.32E-09 0.0057 0.0513 
 rs7834973 8:69639672 C8orf34 T G 0.609 -0.0068 0.0012 4.20E-09 -0.0068 0.0012 4.26E-09 0.0142 0.1278 
 rs12308843 12:23974404 SOX5 G C 0.764 -0.0103 0.0013 9.40E-15 -0.0103 0.0013 9.44E-15 0.0091 0.0819 
 rs2391333 13:107166694 EFNB2 C T 0.615 -0.0066 0.0012 1.90E-08 -0.0066 0.0012 1.87E-08 0.0005 0.0045 
Table 3 – Results of replication of genome-wide significant loci in males and females 









T (A) C (G) 0.453 
(0.010) 
43,740 -2.992 0.0028 ---+ 58.2 7.2 (3) 0.066 
rs72922230 rs11665656 
(GS) 
A (G) G (A) 0.585 
(0.013) 




T (A) TAC (G) 0.631 
(0.022) 
50,092 1.693 0.0904 +--+ 0.0 2.7 (3) 0.444 
rs62327819 (LD = 1 




C (T) T (C) 0.316 
(0.005) 
50,092 2.818 0.0048 ++-+ 47.8 5.7 (3) 0.125 
rs1039325  T G 0.406 
(0.007) 
50,092 -1.594 0.1109 --+- 34.1 4.5 (3) 0.208 
rs116007789  C T 0.999 
(0.001) 
49,083 0.615 0.5385 -+?+ 66.6 6.0 (2) 0.050 
rs7834973  T G 0.608 
(0.003) 




G (C) C (A) 0.769 
(0.006) 
50,092 -1.885 0.0595 ---- 0.0 1.6 (3) 0.667 
rs2391333  C T 0.588 
(0.022) 
50,092 2.237 0.0253 ++-+ 25.9 4.0 (3) 0.256 
Legend to table 3: * Effect and other alleles for replication SNP; corresponding alleles for proxy SNPs are given in brackets; ** Mean effect allele frequency 
(standard error); *** In the order of HUNT, GS, OPPERA, ELSA. Bolded are statistically significant results after correction for 9 tests (p<0.0056). 
Table 4 – Replication of SNP-by-sex interaction signals 
SNP Cohort Males Females t-statistic df Pint Pmeta 
EAF Effect 
size 
SE P-value EAF Effect 
size 
SE P-value  
rs367563576 UK Biobank 0.609 0.0018 0.0012 0.1600 0.609 0.0067 0.0012 7.6E-09 -2.923 392750 0.0035  




0.588 -0.0066 0.0061 0.2768 0.5923 -0.0028 0.0055 0.6083 -0.502 17374 0.6157  
OPPERA 0.605 0.0277 0.1362 0.8385 0.604 -0.0229 0.0951 0.8098 0.304 1126 0.7612  
HUNT 
(rs7513205) 
0.642 0.0012 0.0034 0.7325 0.644 0.0076 0.0036 0.0327 -1.277 59599 0.2017  




UK Biobank 0.316 0.0037 0.0013 0.0044 0.314 -0.0068 0.0012 1.40E-08 6.056 392624 1.40E-09  
Replication cohorts 0.0035 
Generation 
Scotland 
0.314 -0.0083 0.0065 0.2044 0.315 0.0030 0.0059 0.6093 -1.299 17451 0.1940  
OPPERA 0.318 -0.4069 0.1393 0.0035 0.292 -0.0357 0.1000 0.7210 -2.161 1153 0.0309  
HUNT 0.321 -0.0043 0.0036 0.2327 0.319 0.0084 0.0037 0.0221 -2.515 59556 0.0119  
ELSA 0.310 0.0072 0.0109 0.5077 0.305 0.0327 0.0115 0.0045 -1.441 5889 0.1495  
rs1039325 UK Biobank 0.415 -0.0016 0.0012 0.2000 0.417 -0.0065 0.0011 8.7E-09 2.996 392332 0.0027  
Replication cohorts 0.6567 
Generation 
Scotland 
0.418 -0.0080 0.0061 0.1909 0.416 -0.0112 0.0090 0.2151 0.235 19277 0.8142  
OPPERA 0.417 0.2957 0.1279 0.0208 0.417 0.1211 0.0914 0.1852 1.109 1148 0.2678  
HUNT 0.402 -0.0034 0.0034 0.3204 0.401 -0.0031 0.0035 0.3706 -0.094 59570 0.9254  
ELSA 0.413 -0.0004 0.0104 0.9718 0.418 -0.0185 0.0107 0.0835 1.133 5832 0.2574  
rs2391333 UK Biobank 0.616 -0.0007 0.0013 0.5700 0.615 -0.0066 0.0012 1.9E-08 3.458 392630 0.0005  
Replication cohorts 0.1397 
Generation 
Scotland 
0.613 0.0062 0.0062 0.3140 0.618 -0.0054 0.0092 0.5550 1.062 19250 0.2884  
OPPERA 0.625 -0.0215 0.1254 0.8635 0.615 -0.1108 0.0926 0.2314 0.5720 1180 0.5675  
HUNT 0.571 -0.0032 0.0034 0.3513 0.573 0.0071 0.0035 0.0447 -2.124 59606 0.0336  
ELSA 0.615 0.0052 0.0103 0.6131 0.629 0.0196 0.0109 0.0719 -0.853 5893 0.3939  
Legend to table 4: SNP-by-sex interaction analysis was carried out by comparing effect sizes in males and females as detailed in Methods. Pint, p-value for 
SNP-by-sex interaction; Pmeta, p-value for Fisher’s combined probability test. Highlighted are nominally significant associations or interactions. Details of 





Table 5 – SNP-based heritability of chronic BP by age and sex in the UK Biobank 
Age group All Males Females P-value for 
males vs females 
Total sample 0.068±0.002 0.067±0.003 0.079±0.003 0.005 
“Younger than 65” 0.069±0.002 0.068±0.004 0.080±0.003 0.033 
“65+” 0.066±0.007 0.046±0.013 0.098±0.013 0.005 
P-value for 
“Younger than 
65” vs “65+” 
0.699 0.092 0.198  
Legend to table 5: SNP-based heritability was calculated using REML algorithm implemented in 
BOLT-LMM software; p-values of male vs female and between-age group differences are given. 
 
  
Table 6 – Genetic correlation between cBP and 10 risk factors in males and females 
Trait Males Females Pdiff 
rg p-value rg p-value Raw Adjusted 
Intervertebral disc problems 
(self-reported) 0.889 5.6E-19 0.638 1.6E-14 3.7E-07 3.7E-06 
Osteoarthritis 0.494 6.1E-19 0.599 3.4E-36 0.042 0.420 
BMI 0.291 6.7E-28 0.357 9.9E-46 0.045 0.450 
Scoliosis 0.220 0.089 0.433 5.9E-05 0.156 1.000 
Smoking 0.343 2.2E-26 0.325 5.8E-27 0.650 1.000 
Depression 0.395 7.3E-12 0.408 5.9E-16 0.835 1.000 
Fluid intelligence score -0.309 2.2E-17 -0.289 3.5E-19 0.643 1.000 
Happiness/wellbeing 0.172 0.002 0.160 0.004 0.873 1.000 
Anxiety/panic attacks  0.208 0.017 0.192 0.010 0.883 1.000 
Educational attainment -0.408 3.2E-43 -0.438 1.3E-70 0.319 1.000 
Legend to Table 6: Genetic correlation between chronic BP and putative risk factors for BP, by sex 
and comparison thereof before (Pdiff Raw) and after adjustment for 10 tests (Pdiff Adjusted).  
 
 
 
